Atrium Therapeutics, Inc. <RNA.O>: H.C. Wainwright initiates coverage with buy rating and target price $25
RNA•Related News
Solventum Corporation <SOLV.N>: Mizuho Raises Target Price to $113 From $100
SOLV•
Dynatrace, Inc <DT.N>: BMO raises target price to $60 from $50
DT•
Somnigroup Q2 FY26 EPS rises 10.6% to $0.52; net sales fall 3% to $1.82 billion
SGI•
Paycom Software, Inc. <PAYC.N>: Mizuho raises target price to $160 from $130
PAYC•
Vontier acquires fleet management software provider EKOS
VNT•